Plasma B-type natriuretic peptide levels in cardiac donors

Clinical Transplantation

Volumn 23, Issue 2, 2009, Pages 174-177

  Amir, Nezar L ^a   Gerber, Ivor L ^a   Edmond, John J ^a   Langlands, Janice M ^a   Richards, A Mark ^b   Ruygrok, Peter N ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Cardiac; Donor; Natriuretic peptides; Transplant

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AORTA BALLOON; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR SELECTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MICROCLIMATE; MORTALITY; ORGAN DONOR; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME;

ADULT; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 64349099118     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00954.x     Document Type: Article

References (15)

1. Chen JM, Sinha P, Eng M et al. Do donor characteristics really matter? Short and long term impact of donor characteristics on recipient survival 1995-1999. J Heart Lung Transplant 2002: 21: 608.
2. Leitz K, Ranjit J, Mancini D et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list. J Am Coll Cardiol 2004: 43: 1553.
3. Ibrahim M, Masters RG, Hendry PJ et al. Determinants of hospital survival after cardiac transplant. Ann Thorac Surg 1995: 59: 604.
4. Patel J, Kobashigawa JA. Cardiac transplantation: The alternate list and expansion of the donor pool. Curr Opin Cardiol 2004: 19: 162.
5. Massad MG. Current trends in heart transplantation. Cardiology 2004: 101: 79.
6. Zaroff J. Echocardiographic evaluation of the potential cardiac donor. J Heart Lung Transplant 2004: 23: 250.
7. Zaroff JG, Babcock W, Shiboski S. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 2003: 21: 1153.
8. Dokainish H, Zoghbi WA, Lakkis NM et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005: 45: 1223.
9. Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: Correlation with cardiac function, hemodynamics, and workload. Am Heart J 2004: 148: 365.
10. Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 2003: 92: 1434.
11. Kuster GM, Tanner H, Printzen G, Suter TM. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly 2002: 132: 623.
12. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 1997: 47: 287.
13. Hosenpud JD, Bennett LE, Keck BM et al. International Heart and Lung Transplant Data Registry 2001. J Heart Lung Transplant 2001: 20: 805.
14. Luckraz H, Goddard M, Charman SC et al. Early mortality after cardiac transplantation: Should we do better? J Heart Lung Transplant 2005: 24: 401.
15. Hosenpud JD, Bennett LE, Keck BM et al. International Heart and Lung Transplant Data Registry 2000. J Heart Lung Transplant 2000: 19: 909.